GEICO1601-ROLANDO trial: A multicentric single arm phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer

Simple item page
dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorPerez Fidalgo, J. A.
dc.contributor.authorCortes, A.
dc.contributor.authorGarcia, Y.
dc.contributor.authorIglesias, M.
dc.contributor.authorBohn Sarmiento, U.
dc.contributor.authorCalvo Garcia, E.
dc.contributor.authorManso Sanchez, L.
dc.contributor.authorSantaballa, A.
dc.contributor.authorOaknin, A.
dc.contributor.authorRedondo, A.
dc.contributor.authorRubio, M. J.
dc.contributor.authorGonzalez Martin, A.
dc.contributor.authoraffiliation[Perez Fidalgo, J. A.] Hosp Clinico Univ Valencia, Dept Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Cortes, A.] Hosp Univ Ramon & Cajal, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Garcia, Y.] Hosp Sabadell, Med Oncol, Sabadell, Spain
dc.contributor.authoraffiliation[Iglesias, M.] Hosp Son Llatzer, Med Oncol, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Bohn Sarmiento, U.] Hosp Univ Gran Canaria Doctor Negrin, Med Oncol, Las Palmas Gran Canaria, Spain
dc.contributor.authoraffiliation[Calvo Garcia, E.] Hosp Univ Virgen del Rocio, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Manso Sanchez, L.] Hosp Univ 12 Octubre, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Santaballa, A.] Hosp Univ & Politecn La Fe, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Oaknin, A.] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Redondo, A.] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Rubio, M. J.] Univ Hosp Reina Sofia, Med Oncol, Cordoba, Spain
dc.contributor.authoraffiliation[Gonzalez Martin, A.] Clin Univ Navarra, Dept Med Oncol, Madrid, Spain
dc.contributor.funderAstraZeneca
dc.date.accessioned2025-01-07T13:53:24Z
dc.date.available2025-01-07T13:53:24Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.971
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420409676/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25936
dc.identifier.wosID573469101120
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS626-S626
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleGEICO1601-ROLANDO trial: A multicentric single arm phase II clinical trial to evaluate the combination of olaparib and pegylated liposomal doxorubicin for platinum-resistant ovarian cancer
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Reina Sofía
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía